Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.16%
#2 0G 0G +29.67%
#3 Nockchain Nockchain +23.93%
#4 Zora Zora +23.55%
#5 Fake World Assets Fake World Assets +19.22%
#6 Full Moon Full Moon +17.70%
#7 Axelar Axelar +17.49%
#8 Notcoin Notcoin +16.89%
#9 ADO Protocol ADO Protocol +15.48%
#10 SAFEcoin SAFEcoin +13.35%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Settings
Language
ENGLISH
Currency
USD
Theme
Zhejiang Starry Pharmaceutical Co.,Ltd. Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd.

603520
Rank in Stocks #12610
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry... Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate. For fluoroquinolones, their offerings feature levofloxacin (and its hydrochloride salt), levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate.
Share Price
$1.29
Market Cap
$567.34M
Change (1 day)
-1.33%
Change (1 year)
-20.72%
Country
CN
Trade Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)

Category

Healthcare
Revenue for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)
Revenue in Aug 2026 TTM: 0
According to Zhejiang Starry Pharmaceutical Co.,Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zhejiang Starry Pharmaceutical Co.,Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH